"Macrophage Migration-Inhibitory Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell.
Descriptor ID |
D008263
|
MeSH Number(s) |
D12.644.276.374.480.625 D12.776.467.374.480.625 D23.125.477.500 D23.529.374.480.625
|
Concept/Terms |
Macrophage Migration-Inhibitory Factors- Macrophage Migration-Inhibitory Factors
- Macrophage Migration Inhibitory Factors
- Migration-Inhibitory Factors, Macrophage
- Macrophage Migration Inhibition Factors
- Migration Inhibition Factors, Macrophage
|
Below are MeSH descriptors whose meaning is more general than "Macrophage Migration-Inhibitory Factors".
Below are MeSH descriptors whose meaning is more specific than "Macrophage Migration-Inhibitory Factors".
This graph shows the total number of publications written about "Macrophage Migration-Inhibitory Factors" by people in this website by year, and whether "Macrophage Migration-Inhibitory Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 |
2006 | 1 | 1 | 2 |
2008 | 1 | 1 | 2 |
2013 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macrophage Migration-Inhibitory Factors" by people in Profiles.
-
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis. Int J Mol Sci. 2019 Jul 31; 20(15).
-
Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care. 2013 Jun; 36(6):1703-11.
-
The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators--the Finnish Diabetes Prevention Study. Genet Med. 2008 Jul; 10(7):536-44.
-
Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis. 2008 Oct; 200(2):380-8.
-
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes. 2006 Aug; 55(8):2340-6.
-
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care. 2006 Feb; 29(2):368-71.
-
Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology. 2005 Mar; 146(3):1006-11.